At the European Society for the Study of Diabetes (EASD) Annual Meeting in Barcelona, Clifford Bailey discusses the findings of the EMPA-REG trial and what this has taught us about the heart failure and diabetes.
Questions
1. What are the major types of cardiac dysfunction in diabetes? (0:05)
2. What is the impact of intensive glucose lowering on heart failure incidence in patients with diabetes? (2:22)
3. What have the findings of the EMPA-REG trial taught us about the optimal treatment of patients with diabetes and heart failure? (4:33)
Clifford Bailey has no conflicts of interest to declare in relation to this video.
Filmed at the Annual Meeting of the European Association of the Study of Diabetes (EASD) Barcelona, Spain 2019.
